Helius Medical Technologies Inc Class A Net Assets
Helius Medical Technologies Inc Class A net assets. Based on the latest financial reports, Helius Medical Technologies Inc Class A (HSDT) has net assets worth $-152.39 Million USD as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($475.92 Million) and total liabilities ($628.31 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Also explore Helius Medical Technologies Inc Class A annual equity growth to track the company's year-over-year net asset growth rate.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $-152.39 Million |
| % of Total Assets | -32.02% |
| Annual Growth Rate | N/A |
| 5-Year Change | -72.64% |
| 10-Year Change | N/A |
| Growth Volatility | 89.26 |
Net Assets of Helius Medical Technologies Inc Class A (2013–2024)
Net assets of Helius Medical Technologies Inc Class A from 2013 to 2024. This chart illustrates how Helius Medical Technologies Inc Class A's net assets have evolved over time, based on quarterly financial data. See HSDT equity financing ratio to measure how much of total assets are equity-financed.
Annual Net Assets for Helius Medical Technologies Inc Class A (2013–2024)
The table below shows the annual net assets of Helius Medical Technologies Inc Class A from 2013 to 2024. For live market cap and overall valuation, see Helius Medical Technologies Inc Class A (HSDT) total market value.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $1.06 Million | -54.94% |
| 2023-12-31 | $2.35 Million | -71.17% |
| 2022-12-31 | $8.15 Million | -27.59% |
| 2021-12-31 | $11.26 Million | +190.78% |
| 2020-12-31 | $3.87 Million | -33.66% |
| 2019-12-31 | $5.83 Million | -40.79% |
| 2018-12-31 | $9.85 Million | +231.56% |
| 2017-12-31 | $-7.49 Million | -46154.55% |
| 2016-12-31 | $-16.19K | -0.01% |
| 2015-12-31 | $-16.19K | +98.96% |
| 2014-12-31 | $-1.56 Million | -483.22% |
| 2013-12-31 | $-267.98K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Helius Medical Technologies Inc Class A's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 16211386600.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Helius Medical Technologies Inc Class A Net Assets Breakdown (December 2024)
Helius Medical Technologies Inc Class A net assets breakdown by equity component as of December 2024.
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $4.00K | 0.38% |
| Other Comprehensive Income | $333.00K | 31.44% |
| Other Components | $172.42 Million | 16281.49% |
| Total Equity | $1.06 Million | 100.00% |
Helius Medical Technologies Inc Class A Competitors by Market Cap
The table below lists competitors of Helius Medical Technologies Inc Class A ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Rorze Systems Corporation
KQ:071280
|
$81.38 Million |
|
Agabang&Company
KQ:013990
|
$81.39 Million |
|
Euroapi SAS
PA:EAPI
|
$81.43 Million |
|
Mukka Proteins Limited
NSE:MUKKA
|
$81.43 Million |
|
ST Dupont
PA:DPT
|
$81.35 Million |
|
Tecnisa S.A
SA:TCSA3
|
$81.33 Million |
|
SV Investment Corporation
KQ:289080
|
$81.30 Million |
|
Fuzetec Technology Co Ltd
TWO:6642
|
$81.30 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Helius Medical Technologies Inc Class A's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 2,350,000 to 1,059,000, a change of -1,291,000 (-54.9%).
- Net loss of 11,742,000 reduced equity.
- New share issuances of 2,961,000 increased equity.
- Other comprehensive income increased equity by 1,006,000.
- Other factors increased equity by 6,484,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-11.74 Million | -1108.78% |
| Share Issuances | $2.96 Million | +279.6% |
| Other Comprehensive Income | $1.01 Million | +95.0% |
| Other Changes | $6.48 Million | +612.28% |
| Total Change | $- | -54.94% |
Book Value vs Market Value Analysis
This analysis compares Helius Medical Technologies Inc Class A's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.01x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2013-12-31 | $-33497.13 | $2.10 | x |
| 2014-12-31 | $-156290.10 | $2.10 | x |
| 2015-12-31 | $-1619.20 | $2.10 | x |
| 2016-12-31 | $-1619.20 | $2.10 | x |
| 2017-12-31 | $-527464.79 | $2.10 | x |
| 2018-12-31 | $567626.73 | $2.10 | x |
| 2019-12-31 | $290587.65 | $2.10 | x |
| 2020-12-31 | $121195.99 | $2.10 | x |
| 2021-12-31 | $171821.10 | $2.10 | x |
| 2022-12-31 | $22646.70 | $2.10 | x |
| 2023-12-31 | $2899.37 | $2.10 | x |
| 2024-12-31 | $293.10 | $2.10 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Helius Medical Technologies Inc Class A utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -1108.78%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: -2258.08%
- • Asset Turnover: 0.15x
- • Equity Multiplier: 3.34x
- Recent ROE (-1108.78%) is below the historical average (-220.19%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | 0.00% | 0.00% | 0.00x | 0.00x | $-1.04 Million |
| 2014 | 0.00% | 0.00% | 0.00x | 0.00x | $-9.68 Million |
| 2015 | 0.00% | 0.00% | 0.00x | 0.00x | $-6.88 Million |
| 2016 | 0.00% | 0.00% | 0.00x | 0.00x | $-6.88 Million |
| 2017 | 0.00% | 0.00% | 0.00x | 0.00x | $-27.27 Million |
| 2018 | -290.47% | -5988.08% | 0.02x | 2.82x | $-29.61 Million |
| 2019 | -167.63% | -653.81% | 0.14x | 1.77x | $-10.36 Million |
| 2020 | -365.02% | -2137.67% | 0.10x | 1.69x | $-14.52 Million |
| 2021 | -161.09% | -3473.56% | 0.04x | 1.25x | $-19.26 Million |
| 2022 | -172.64% | -1788.06% | 0.05x | 2.12x | $-14.89 Million |
| 2023 | -376.60% | -1374.22% | 0.08x | 3.27x | $-9.09 Million |
| 2024 | -1108.78% | -2258.08% | 0.15x | 3.34x | $-11.85 Million |
Industry Comparison
This section compares Helius Medical Technologies Inc Class A's net assets metrics with peer companies in the Asset Management industry.
Industry Context
- Industry: Asset Management
- Average net assets among peers: $606,357,977
- Average return on equity (ROE) among peers: -27.23%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Helius Medical Technologies Inc Class A (HSDT) | $-152.39 Million | 0.00% | N/A | $81.36 Million |
| Acadian Asset Management Inc (AAMI) | $170.50 Million | 74.13% | 6.59x | $3.22 Billion |
| AllianceBernstein Holding L.P. (AB) | $1.63 Billion | 10.97% | 0.00x | $3.21 Billion |
| Associated Capital Group Inc (AC) | $948.70 Million | 4.12% | 0.07x | $78.56 Million |
| Abrdn Emerging Markets Equity Income Fund Inc (AEF) | $302.50 Million | 9.63% | 0.14x | $265.69 Million |
| AFC Gamma Inc (AFCG) | $175.57 Million | -11.78% | 0.57x | $71.91 Million |
| AgriFORCE Growing Systems Ltd (AGRI) | $-40.08K | 0.00% | 0.00x | $194.14 Million |
| Alpha Compute Corp (ALP) | $4.53 Million | -55.38% | 0.03x | $5.62 Million |
| Alvarium Tiedemann Holdings Inc. (ALTI) | $970.20 Million | -10.62% | 0.29x | $267.43 Million |
| Amber International Holding Limited (AMBR) | $13.39 Million | -296.55% | 9.91x | $159.70 Million |
| Affiliated Managers Group, Inc. (AMG) | $1.85 Billion | 3.21% | 0.83x | $9.63 Billion |
About Helius Medical Technologies Inc Class A
Solana Company operates as a listed digital asset treasury. It enhances SOL per share on the commercially viable blockchain for decentralized finance and consumer applications. The company is headquartered in Newtown, Pennsylvania.